Mainz Biomed NV (Mainz Biomed NV) Accounts Payable & Accrued Expense : $3.48 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Accounts Payable & Accrued Expense?

Mainz Biomed NV's quarterly accounts payable & accrued expense declined from Jun. 2023 ($4.72 Mil) to Sep. 2023 ($3.10 Mil) but then increased from Sep. 2023 ($3.10 Mil) to Dec. 2023 ($3.48 Mil).

Mainz Biomed NV's annual accounts payable & accrued expense increased from Dec. 2021 ($1.10 Mil) to Dec. 2022 ($2.72 Mil) and increased from Dec. 2022 ($2.72 Mil) to Dec. 2023 ($3.48 Mil).

Mainz Biomed NV Accounts Payable & Accrued Expense Historical Data

The historical data trend for Mainz Biomed NV's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Accounts Payable & Accrued Expense Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

0.25

0.44

1.10

2.72

3.48

Mainz Biomed NV Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial								2.72	3.15	4.72	3.10	3.48

Mainz Biomed NV Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Mainz Biomed NV (Mainz Biomed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

4TO:Germany

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.